Literature DB >> 12029017

The serum S100B concentration is age dependent.

Luis V C Portela1, Adriano B L Tort, Débora V Schaf, Luciana Ribeiro, Daniel B Nora, Roger Walz, Liane N Rotta, Cátia T Silva, João V Busnello, Flávio Kapczinski, Carlos A Gonçalves, Diogo O Souza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12029017

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  34 in total

1.  Developmental changes in S100B content in brain tissue, cerebrospinal fluid, and astrocyte cultures of rats.

Authors:  Francine Tramontina; Sabrina Conte; Daniela Gonçalves; Carmem Gottfried; Luis V Portela; Lucia Vinade; Christianne Salbego; Carlos-Alberto Gonçalves
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

2.  S100beta protein expression: gender- and age-related daily changes.

Authors:  M I Nogueira; S Y Abbas; L G M Campos; W Allemandi; P Lawson; S H Takada; E C Azmitia
Journal:  Neurochem Res       Date:  2009-02-11       Impact factor: 3.996

Review 3.  S100B as a marker for brain damage and blood-brain barrier disruption following exercise.

Authors:  Serene X T Koh; Jason K W Lee
Journal:  Sports Med       Date:  2014-03       Impact factor: 11.136

4.  Serum levels of S100B are decreased in chronic starvation and normalize with weight gain.

Authors:  Kristian Holtkamp; Katharina Bühren; Gerald Ponath; Christoph von Eiff; Beate Herpertz-Dahlmann; Johannes Hebebrand; Matthias Rothermundt
Journal:  J Neural Transm (Vienna)       Date:  2008-04-02       Impact factor: 3.575

5.  Neuron-specific enolase, but not S100B or myelin basic protein, increases in peripheral blood corresponding to lesion volume after cortical impact in piglets.

Authors:  Beth A Costine; Patricia B Quebeda-Clerkin; Carter P Dodge; Brent T Harris; Simon C Hillier; Ann-Christine Duhaime
Journal:  J Neurotrauma       Date:  2012-09-27       Impact factor: 5.269

6.  Common data elements for pediatric traumatic brain injury: recommendations from the biospecimens and biomarkers workgroup.

Authors:  Rachel P Berger; Sue R Beers; Linda Papa; Michael Bell
Journal:  J Neurotrauma       Date:  2011-11-22       Impact factor: 5.269

Review 7.  Clinical applications of biomarkers in pediatric traumatic brain injury.

Authors:  Simon J I Sandler; Anthony A Figaji; P David Adelson
Journal:  Childs Nerv Syst       Date:  2009-11-10       Impact factor: 1.475

8.  S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond.

Authors:  Guglielmo Sorci; Roberta Bianchi; Francesca Riuzzi; Claudia Tubaro; Cataldo Arcuri; Ileana Giambanco; Rosario Donato
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-18

9.  Effects of S100B on Serotonergic Plasticity and Neuroinflammation in the Hippocampus in Down Syndrome and Alzheimer's Disease: Studies in an S100B Overexpressing Mouse Model.

Authors:  Lee A Shapiro; Lynn A Bialowas-McGoey; Patricia M Whitaker-Azmitia
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-22

10.  Serum levels of S100B and NSE proteins in Alzheimer's disease patients.

Authors:  Márcia L Chaves; Ana L Camozzato; Eduardo D Ferreira; Isabel Piazenski; Renata Kochhann; Oscar Dall'Igna; Guilherme S Mazzini; Diogo O Souza; Luis V Portela
Journal:  J Neuroinflammation       Date:  2010-01-27       Impact factor: 8.322
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.